Jiao, Yinping
Peluso, Paul
Shi, Jinghua
Liang, Tiffany
Stitzer, Michelle C.
Wang, Bo
Campbell, Michael S.
Stein, Joshua C.
Wei, Xuehong
Chin, Chen-Shan
Guill, Katherine
Regulski, Michael
Kumari, Sunita
Olson, Andrew
Gent, Jonathan
Schneider, Kevin L.
Wolfgruber, Thomas K.
May, Michael R.
Springer, Nathan M.
Antoniou, Eric
McCombie, W. Richard
Presting, Gernot G.
McMullen, Michael
Ross-Ibarra, Jeffrey
Dawe, R. Kelly
Hastie, Alex
Rank, David R.
Ware, Doreen
Article History
Received: 27 September 2016
Accepted: 14 May 2017
First Online: 12 June 2017
Competing interests
: P.P., C.-S.C. and D.R.R. are full-time employees of Pacific Biosciences. J.S., T.L. and A.H. are employees of BioNano Genomics, Inc., and own company stock options. W.R.M. has participated in Illumina sponsored meetings over the past four years and received travel reimbursement and an honorarium for presenting at these events. Illumina had no role in decisions relating to the study/work to be published, data collection and analysis of data, or the decision to publish. W.R.M. has participated in Pacific Biosciences sponsored meetings over the past three years and received travel reimbursement for presenting at these events. W.R.M. is a founder and shared holder of Orion Genomics, which focuses on plant genomics and cancer genetics. W.R.M. is an SAB member for RainDance Technologies, Inc. All other authors declare no competing financial interests.